Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siwei Li

Showing results (261-270 of 275) with videos related to

Pageof 28
Sort By:
Molecular Pharmaceutics|December 24, 2016
Measurement of in vivo Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal TractAlex Yu, Jason R Baker, Ann F Fioritto, et al.
Journal of Medicinal Chemistry|May 3, 2017
Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain InhibitorYujun Zhao, Longchuan Bai, Liu Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2020
The quest for improved air quality may push China to continue its CO<sub>2</sub> reduction beyond the Paris CommitmentJia Xing, Xi Lu, Shuxiao Wang, et al.
Journal of Medicinal Chemistry|September 18, 2018
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer ChemotherapyBrandt C Huddle, Edward Grimley, Cameron D Buchman, et al.
European Journal of Medicinal Chemistry|December 20, 2020
Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapyBrandt C Huddle, Edward Grimley, Mikhail Chtcherbinine, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 30, 2025
Engineered crRNA Drives RPA-T7-CRISPR/Cas14a Cascade for Ultrasensitive Detection of ctDNA PIK3CA H1047RYuanyuan Yu, Mengru Jin, Weiguang Yuan, et al.
The Science of the Total Environment|January 13, 2023
Sulfur dioxide may predominate in the adverse effects of ambient air pollutants on semen quality among the general population in Hefei, ChinaFeng Zhang, Hang Li, Wenting Xu, et al.
Nanoscale|December 12, 2025
iRGD-engineered exosomes mediate siMYC delivery for effective tumor suppression in triple-negative breast cancerHui Li, Weiguang Yuan, Jialin Liu, et al.
Journal of Medicinal Chemistry|July 18, 2018
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain InhibitorYujun Zhao, Bing Zhou, Longchuan Bai, et al.
Environmental Science & Technology|August 12, 2024
Air Quality, Health, and Equity Benefits of Carbon Neutrality and Clean Air Pathways in ChinaYisheng Sun, Yueqi Jiang, Jia Xing, et al.
Pageof 28

Showing results (261-270 of 275) with videos related to

Sort By:
Pageof 28
Molecular Pharmaceutics|December 24, 2016
Measurement of in vivo Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal TractAlex Yu, Jason R Baker, Ann F Fioritto, et al.
Journal of Medicinal Chemistry|May 3, 2017
Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain InhibitorYujun Zhao, Longchuan Bai, Liu Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2020
The quest for improved air quality may push China to continue its CO<sub>2</sub> reduction beyond the Paris CommitmentJia Xing, Xi Lu, Shuxiao Wang, et al.
Journal of Medicinal Chemistry|September 18, 2018
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer ChemotherapyBrandt C Huddle, Edward Grimley, Cameron D Buchman, et al.
European Journal of Medicinal Chemistry|December 20, 2020
Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapyBrandt C Huddle, Edward Grimley, Mikhail Chtcherbinine, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 30, 2025
Engineered crRNA Drives RPA-T7-CRISPR/Cas14a Cascade for Ultrasensitive Detection of ctDNA PIK3CA H1047RYuanyuan Yu, Mengru Jin, Weiguang Yuan, et al.
The Science of the Total Environment|January 13, 2023
Sulfur dioxide may predominate in the adverse effects of ambient air pollutants on semen quality among the general population in Hefei, ChinaFeng Zhang, Hang Li, Wenting Xu, et al.
Nanoscale|December 12, 2025
iRGD-engineered exosomes mediate siMYC delivery for effective tumor suppression in triple-negative breast cancerHui Li, Weiguang Yuan, Jialin Liu, et al.
Journal of Medicinal Chemistry|July 18, 2018
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain InhibitorYujun Zhao, Bing Zhou, Longchuan Bai, et al.
Environmental Science & Technology|August 12, 2024
Air Quality, Health, and Equity Benefits of Carbon Neutrality and Clean Air Pathways in ChinaYisheng Sun, Yueqi Jiang, Jia Xing, et al.
Pageof 28